Matches in SemOpenAlex for { <https://semopenalex.org/work/W2754294894> ?p ?o ?g. }
- W2754294894 endingPage "767" @default.
- W2754294894 startingPage "731" @default.
- W2754294894 abstract "In recent years, there has been growing interest in the possible use of nutraceuticals to improve and optimize dyslipidemia control and therapy. Based on the data from available studies, nutraceuticals might help patients obtain theraputic lipid goals and reduce cardiovascular residual risk. Some nutraceuticals have essential lipid-lowering properties confirmed in studies; some might also have possible positive effects on nonlipid cardiovascular risk factors and have been shown to improve early markers of vascular health such as endothelial function and pulse wave velocity. However, the clinical evidence supporting the use of a single lipid-lowering nutraceutical or a combination of them is largely variable and, for many of the nutraceuticals, the evidence is very limited and, therefore, often debatable. The purpose of this position paper is to provide consensus-based recommendations for the optimal use of lipid-lowering nutraceuticals to manage dyslipidemia in patients who are still not on statin therapy, patients who are on statin or combination therapy but have not achieved lipid goals, and patients with statin intolerance. This statement is intended for physicians and other healthcare professionals engaged in the diagnosis and management of patients with lipid disorders, especially in the primary care setting." @default.
- W2754294894 created "2017-09-25" @default.
- W2754294894 creator A5000498350 @default.
- W2754294894 creator A5002163579 @default.
- W2754294894 creator A5008640203 @default.
- W2754294894 creator A5009748162 @default.
- W2754294894 creator A5011747612 @default.
- W2754294894 creator A5021398096 @default.
- W2754294894 creator A5024562464 @default.
- W2754294894 creator A5024586791 @default.
- W2754294894 creator A5025058942 @default.
- W2754294894 creator A5031560022 @default.
- W2754294894 creator A5035962648 @default.
- W2754294894 creator A5040337000 @default.
- W2754294894 creator A5045816461 @default.
- W2754294894 creator A5046258505 @default.
- W2754294894 creator A5046431472 @default.
- W2754294894 creator A5048145643 @default.
- W2754294894 creator A5048623628 @default.
- W2754294894 creator A5049796469 @default.
- W2754294894 creator A5054876477 @default.
- W2754294894 creator A5056740369 @default.
- W2754294894 creator A5058321397 @default.
- W2754294894 creator A5065701334 @default.
- W2754294894 creator A5068594572 @default.
- W2754294894 creator A5085496501 @default.
- W2754294894 creator A5086073841 @default.
- W2754294894 creator A5086863186 @default.
- W2754294894 creator A5088396929 @default.
- W2754294894 creator A5090081265 @default.
- W2754294894 date "2017-09-01" @default.
- W2754294894 modified "2023-10-18" @default.
- W2754294894 title "Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel" @default.
- W2754294894 cites W1511998280 @default.
- W2754294894 cites W1514644719 @default.
- W2754294894 cites W1528479054 @default.
- W2754294894 cites W1563872854 @default.
- W2754294894 cites W1570369031 @default.
- W2754294894 cites W1587007485 @default.
- W2754294894 cites W1604326213 @default.
- W2754294894 cites W1643244484 @default.
- W2754294894 cites W1768049875 @default.
- W2754294894 cites W1786073935 @default.
- W2754294894 cites W1791446235 @default.
- W2754294894 cites W1836594461 @default.
- W2754294894 cites W1836683183 @default.
- W2754294894 cites W1894574165 @default.
- W2754294894 cites W1916852161 @default.
- W2754294894 cites W1937861904 @default.
- W2754294894 cites W1944704762 @default.
- W2754294894 cites W1944972564 @default.
- W2754294894 cites W1963595498 @default.
- W2754294894 cites W1964476694 @default.
- W2754294894 cites W1968963621 @default.
- W2754294894 cites W1968993625 @default.
- W2754294894 cites W1969686297 @default.
- W2754294894 cites W1970815707 @default.
- W2754294894 cites W1970822817 @default.
- W2754294894 cites W1972029250 @default.
- W2754294894 cites W1972661406 @default.
- W2754294894 cites W1973557710 @default.
- W2754294894 cites W1974105416 @default.
- W2754294894 cites W1977413585 @default.
- W2754294894 cites W1979837731 @default.
- W2754294894 cites W1980114153 @default.
- W2754294894 cites W1983665424 @default.
- W2754294894 cites W1983997443 @default.
- W2754294894 cites W1984883840 @default.
- W2754294894 cites W1985900911 @default.
- W2754294894 cites W1985920370 @default.
- W2754294894 cites W1988636494 @default.
- W2754294894 cites W1991952379 @default.
- W2754294894 cites W1993012591 @default.
- W2754294894 cites W1994142612 @default.
- W2754294894 cites W1997850002 @default.
- W2754294894 cites W1999897292 @default.
- W2754294894 cites W2000457146 @default.
- W2754294894 cites W2001047720 @default.
- W2754294894 cites W2002289512 @default.
- W2754294894 cites W2003563978 @default.
- W2754294894 cites W2004322550 @default.
- W2754294894 cites W2007709067 @default.
- W2754294894 cites W2008425244 @default.
- W2754294894 cites W2008978505 @default.
- W2754294894 cites W2009668676 @default.
- W2754294894 cites W2010418588 @default.
- W2754294894 cites W2010514535 @default.
- W2754294894 cites W2012254282 @default.
- W2754294894 cites W2013237132 @default.
- W2754294894 cites W2021280617 @default.
- W2754294894 cites W2022169647 @default.
- W2754294894 cites W2023883646 @default.
- W2754294894 cites W2025174283 @default.
- W2754294894 cites W2026310866 @default.
- W2754294894 cites W2026613797 @default.
- W2754294894 cites W2027617880 @default.
- W2754294894 cites W2033346469 @default.
- W2754294894 cites W2034134526 @default.